0769-22660023 On March 29, "Global Vision Correction, Brilliant Intraocular Clarity" — A-ER Eye Hospital Dongguan ICL Surpasses 10,000 Cases & EVO+ICL (V5) Dongguan Premiere Technology Launch was successfully held. This grand event focusing on cutting-edge global refractive technologies not only witnessed A-ER Dongguan’s milestone of over 10,000 ICL procedures but also officially unveiled the new-generation EVO+ICL (V5) technology for the first time in Dongguan.

At this ceremony, President Liu Fei (A-ER Eye Hospital Group Dongguan Region), Director Chen Xiaobei (Refractive Surgery Center, A-ER Eye Hospital Dongguan), and Deputy Director Yin Na were invited to attend. They gathered with citizens who came specially, discussed vision correction with top experts, and witnessed a new milestone in Dongguan’s myopia correction technology.

Driven by original aspiration and unremitting progress, the hospital has won profound trust and sincere preference from the public. The Refractive Surgery Team of A-ER Dongguan has been awarded four additional honorary certifications, building a new height of clear vision with solid strength.
At the ceremony, Mr. Liang Zhihong, representative of STAAR Surgical, presented two certifications to President Liu Fei and Director Chen Xiaobei:
“A-ER Eye Hospital Dongguan EVO ICL Surpasses 10,000 Procedures”
“EVO+ICL (V5) Clinical Application Cooperation Center”
The milestone of 10,000 cases represents the trust of thousands of myopia patients. The establishment of the V5 Clinical Application Cooperation Center marks a new starting point for delivering higher-quality, more precise, and ultra-clear visual experiences.


This dual honor is a heavy recognition: it not only authoritative affirms the technical strength of our refractive team but also officially makes A-ER Eye Hospital Dongguan the FIRST and ONLY medical institution in Dongguan certified by EVO+ICL (V5), stepping to a new level in alignment with world-leading intraocular lens implantation technology.
The height of technology relies on the expertise of surgeons. ICL surgery demands extremely high standards in surgeon qualification, experience, and precision. Each procedure embodies years of refined skills and rigorous professionalism.
With profound accumulation and outstanding contributions in the ICL field, President Liu Fei and Director Chen Xiaobei were specially awarded EVO+ICL (V5) Surgical Certification, becoming among the FIRST batch of certified surgeons nationwide for this technology. This fully demonstrates A-ER Dongguan’s authoritative position in ICL surgery.

In the future, A-ER Eye Hospital Dongguan will continue to leverage global leading technologies and give full play to the leading role of President Liu Fei and Director Chen Xiaobei as national first-batch V5-certified surgeons. With more exquisite medical skills and richer experience, it will bring clear, comfortable, and reassuring visual renewal to more patients pursuing high-quality vision.
Amid rapid iteration of myopia correction, innovative procedures increasingly meet public visual demands. As an upgraded flagship of the ICL family, EVO+ICL (V5) has become a highly anticipated “new favorite” with breakthrough technical optimizations.
Its launch relies on strict official selection: A-ER Dongguan passed rigorous reviews with strong medical strength, standardized diagnosis, and rich clinical experience, becoming Dongguan’s first and only officially certified EVO+ICL (V5) institution, with priority access to V5 lenses, eliminating long waiting times for patients.
President Liu Fei — member of Guangdong Medical Doctor Association, senior expert in triple-category ophthalmic surgery — stated:
Since the first ICL surgery in 2015, we have exceeded 10,000 cases. Evolving from V4, V4c to V5, the technology has achieved three generations of leaps, with surgery duration shortened to about 100 seconds. ICL has shifted from an “alternative option” to a top choice for many myopia patients.
This benefits from safe and flexible lens materials, plus continuous technical upgrades: intraoperative OCT for real-time vault monitoring, 3D dual-navigation for higher precision, comprehensively improving safety and efficiency. All efforts are dedicated to safer, clearer, and more comfortable vision for every patient.

Director Chen Xiaobei — member of the National Youth Expert Collaboration Group for ICL, surgeon with over 6,000 ICL procedures — introduced:
ICL is a cornea-sparing “add-on” surgery that corrects vision by implanting a powered lens. The new V5 lens achieves a key breakthrough based on V4c:
a significantly enlarged optical zone, greatly enhancing night vision clarity, especially for night driving, enabling high-definition vision day and night.
V5: Ideal for patients with large dark pupils, high night-vision demands (driving), pursuit of premium vision.
V4c: More suitable for high myopia over 1400 degrees.

Deputy Director Yin Na — member of Guangdong Optometric Society Refractive Surgery Committee, EVO-ICL Senior Certified Planner — noted:
Relying on A-ER Group’s Full-Solution System, A-ER Dongguan has pioneered advanced procedures including Total Light Sculpt, Robotic SMILE Pro, and now EVO+ICL (V5). It provides truly customized vision correction and broader possibilities for patients pursuing superior visual quality.

In summary, A-ER Dongguan has built a complete Full-Solution System with complete procedures and rapid technological updates, offering diverse and personalized options for myopia patients.
Since the first ICL surgery in April 2015 to the 10,000-case milestone, A-ER Dongguan has upheld the philosophy of “Sharing Global Wisdom”, introduced world-leading refractive technologies, and established a full-procedure matrix covering all myopia groups.
Moving forward, A-ER Eye Hospital Dongguan will continue to take technology as the core, experts as support, and service as foundation, promote the iteration and popularization of refractive surgery, and provide more precise, safer, and higher-quality medical services.